A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : sHLA-G / soluble HLA-G

[Related PubMed/MEDLINE]
Total Number of Papers: 148
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   sHLA-G  (>> Co-occurring Abbreviation)
Long Form:   soluble HLA-G
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Association of HLA-G 3'UTR Polymorphisms with Soluble HLA-G Levels and Disease Activity in Patients with Rheumatoid Arthritis: A Case-Control Study. bp, HLA, PCR-RFLP, RA
2020 HLA-G 14 bp In/Del and +3142 C/G genotypes are differentially expressed between patients with grade IV gliomas and controls. high-grade, HLA-G
2020 HLA-G liver expression and HLA-G extended haplotypes are associated with chronic hepatitis C in HIV-negative and HIV-coinfected patients. HCV, HIV
2020 Increased HLA-G Expression in Tissue-Infiltrating Cells in Inflammatory Bowel Diseases. CD, UC
2020 Integrated analysis of DNA methylation profile of HLA-G gene and imaging in coronary heart disease: Pilot study. Ca, CCTA, CHD
2020 Plasma levels of soluble HLA-G and cytokines in papillary thyroid carcinoma before and after thyroidectomy. PTC
2019 Analysis of circulating soluble programmed death 1 (PD-1), neuropilin 1 (NRP-1) and human leukocyte antigen-G (HLA-G) in psoriatic patients. BSA, HLA-G, NRP-1, PASI, PD-1, PGA, sNRP-1, sPD-1
2019 Association of HLA-G Polymorphisms in the 3'UTR Region and Soluble HLA-G with Kidney Graft Outcome. 3'UTR, HLA-G
2019 Association of Soluble HLA-G Plasma Level and HLA-G Genetic Polymorphism With Pregnancy Outcome of Patients Undergoing in vitro Fertilization Embryo Transfer. HLA, IVF-ETs
10  2019 Donor derived HLA-G polymorphisms have a significant impact on acute rejection in kidney transplantation. bp, HLA-G
11  2019 Effects of recombinant thrombomodulin therapy and soluble human leukocyte antigen-G levels during hematopoietic stem cell transplantation. aGVHD, GVHD, HLA-G, HSCT, IL, rTM, TGF
12  2019 High Expression of HLA-G in Ovarian Carcinomatosis: The Role of Interleukin-1beta. ---
13  2019 HLA-G 3' untranslated region variants +3187G/G, +3196G/G and +3035T define diametrical clinical status and disease outcome in epithelial ovarian cancer. EOC, HLA-G, SNPs, UTR
14  2019 HLA-G expression during hookworm infection in pregnant women. ---
15  2019 HLA-G is upregulated in advanced endometriosis. CTRL, EDT, PF
16  2019 Human leukocyte antigen-G 3' untranslated region polymorphism +3142G/C (rs1063320) and haplotypes are associated with manifestations of the American Tegumentary Leishmaniasis in a Northeastern Brazilian population. ATL, HLA-G, UTR
17  2019 Increased immunomodulatory capacity of human amniotic cells after activation by pro-inflammatory chemokines. hAC
18  2019 Soluble HLA-G levels in seminal plasma are associated with HLA-G 3'UTR genotypes and haplotypes. bp, RM, SNPs, SP, UTR
19  2018 Association between HLA-G 14bp Gene Polymorphism and Serum sHLA-G Protein Concentrations in Preeclamptic Patients and Normal Pregnant Women. bp, HLA-G, MHC, PE
20  2018 Cytokines and soluble HLA-G levels in bone marrow stroma and their association with the survival rate of patients exhibiting childhood T-cell acute lymphoblastic leukemia. T-ALL
21  2018 Elevated soluble human leukocyte antigen G levels in patients after allogeneic stem cell transplantation are associated with less severe acute and chronic graft-versus-host disease. allo-SCT
22  2018 HLA-G Expression in Tumor Tissues and Soluble HLA-G Plasma Levels in Patients with Gastrointestinal Cancer HLA-G
23  2018 HLA-G Haplotypes Are Differentially Associated with Asthmatic Features. HBEC, HLA, TF
24  2018 Human leucocyte antigen-G 14-bp InDel polymorphism and oral squamous cell carcinoma risk in Chinese Han population: A case-control study. 3'-UTR, AUC, CI, HLA-G, InDel, OR, OSCC, ROC
25  2018 Increased plasmatic soluble HLA-G levels in endometrial cancer. EC, HLA-G
26  2018 Soluble HLA-G Expression Inversely Correlates With Fetal Microchimerism Levels in Peripheral Blood From Women With Scleroderma. FMc, HLA
27  2018 The HLA-G 14 bp insertion/deletion polymorphism and its association with soluble HLA-G levels in women with recurrent miscarriages. RM
28  2018 The HLA-G Genetic Contribution to Bipolar Disorder: A Trans-Ethnic Replication. BD, HC, HLA, PCR
29  2018 The role of HLA-G in parasitic diseases. HAT
30  2017 Gene polymorphism and HLA-G expression in patients with childhood-onset systemic lupus erythematosus: A pilot study. 3'UTR, CI, cSLE, HLA-G, IQR, OR, SLE
31  2017 HLA-G promotes myeloid-derived suppressor cell accumulation and suppressive activity during human pregnancy through engagement of the receptor ILT4. GR-MDSCs, HLA-G, IDO, ILT, MDSCs, MHC, PBMCs, STAT3
32  2017 Importance of the plasma soluble HLA-G levels for prognostic stratification with traditional prognosticators in colorectal cancer. CRC
33  2017 Increased levels of soluble HLA-G molecules in Tunisian patients with chronic hepatitis B infection. HBV, HC, HLA-G
34  2017 Low expression of soluble human leukocyte antigen G in early gestation and subsequent placenta-mediated complications of pregnancy. HLA-G
35  2017 Recipient HLA-G +3142 CC Genotype and Concentrations of Soluble HLA-G Impact on Occurrence of CMV Infection after Living-Donor Kidney Transplantation. 3'UTR, CMV, HLA-G, SNP
36  2017 Soluble HLA-G concentrations in obese women during pregnancy and in cord blood. ---
37  2017 Soluble HLA-G is a differential prognostic marker in sequential colorectal cancer disease stages. CRC, LMFS, MC
38  2017 Soluble human leukocyte antigen -G during pregnancy and infancy in Benin: Mother/child resemblance and association with the risk of malaria infection and low birth weight. HLA
39  2016 Correlation of serum sHLA-G levels with cyst stage in patients with cystic echinococcosis: is it an immune evasion strategy? CE, HLA, NK
40  2016 Diagnostic significance of soluble human leukocyte antigen-G for gastric cancer. AFP, CA125, CA19-9, CA72-4, CEA, GC, HLA-G
41  2016 Establishment of optimized ELISA system specific for HLA-G in body fluids. HLA-G, IB, IP, LILR
42  2016 HLA-G 14 bp insertion/deletion polymorphism and its association with sHLA-G levels in Behcet's disease Tunisian patients. HD
43  2016 Human Leukocyte Antigen G Polymorphism and Expression Are Associated with an Increased Risk of Non-Small-Cell Lung Cancer and Advanced Disease Stage. HLA, NSCLC, ROC
44  2016 Human Leukocyte Antigen-G: A Promising Prognostic Marker of Disease Progression to Improve the Control of Human African Trypanosomiasis. HAT, HLA, SERO
45  2016 Immunoregulatory Role of HLA-G in Allergic Diseases. ---
46  2016 Pregnancy and breastfeeding: a new theory for sHLA-G in breast cancer patients? BC
47  2016 Soluble HLA-G concentrations in maternal blood and cervical vaginal fluid of pregnant women with preterm premature rupture of membranes. PPROM
48  2016 The association between functional HLA-G 14bp insertion/deletion and +3142 C>G polymorphisms and susceptibility to multiple sclerosis. 3'UTR, ADO, HD, INS/DEL, MS, RR
49  2016 The impact of HLA-G 3' UTR variants and sHLA-G on risk and clinical correlates of schizophrenia. CGI, HLA, InDel, MHC
50  2016 The impact of IL10 polymorphisms and sHLA-G levels on the risk of schizophrenia. HLA-G, IL-10, SNPs
51  2016 Upregulation of Soluble HLA-G in Chronic Left Ventricular Systolic Dysfunction. EF, HLA-G, LVSD, NT-proBNP, ROC
52  2015 Analysis of HLA-G expression in serum and biopsy samples of kidney transplant recipients. ---
53  2015 Association of soluble human leukocyte antigen-G with acute tubular necrosis in kidney transplant recipients. ATN, HLA
54  2015 High levels of soluble MICA are significantly related to increased disease-free and disease-specific survival in patients with cervical adenocarcinoma. CI, DFS, DSS, ELISA, FIGO, HLA-G, NK, sMICA
55  2015 HLA-G*01:04∼UTR3 Recipient Correlates With Lower Survival and Higher Frequency of Chronic Rejection After Lung Transplantation. DSA
56  2015 Human leukocyte antigen (HLA)-G during pregnancy part II: associations between maternal and fetal HLA-G genotypes and soluble HLA-G. 3'UTR, HLA
57  2015 Human Leukocyte Antigen-G Within the Male Reproductive System: Implications for Reproduction. HLA
58  2015 Human proximal tubule epithelial cells modulate autologous B-cell function. Ab, PTEC
59  2015 Immunosuppressive mediators of oral squamous cell carcinoma in tumour samples and saliva. ELISA, OSCC
60  2015 Role of HLA-G as a predictive marker of low risk of chronic rejection in lung transplant recipients: a clinical prospective study. Abs, BALF, CLAD, HLA-G
61  2015 Significance of tumour cell HLA-G5/-G6 isoform expression in discrimination for adenocarcinoma from squamous cell carcinoma in lung cancer patients. HLA, mAb, NSCLC
62  2015 The Mechanisms of Human Renal Epithelial Cell Modulation of Autologous Dendritic Cell Phenotype and Function. MoDC, PTEC
63  2015 The paradox of high availability and low recognition of soluble HLA-G by LILRB1 receptor in rheumatoid arthritis patients. RA
64  2014 Association of serum soluble human leukocyte antigen-G levels with chronic hepatitis B virus infection. ASC, CH, ENH, HBV, HCC, IC, IT, LR
65  2014 Elevation of human leukocyte antigen-G expression is associated with the severe encephalitis associated with neurogenic pulmonary edema caused by Enterovirus 71. BE, EV71, HLA-G, PE
66  2014 High plasma levels of HLA-G are associated with low birth weight and with an increased risk of malaria in infancy. ---
67  2014 Human leukocyte antigen-G (HLA-G) polymorphism and expression in breast cancer patients. AUROC, ELISA, HLA-G, UTR
68  2014 Infection and HLA-G molecules in nasal polyposis. HPV, IL-10R, mHLA-G, SNP, SNP-WoAD
69  2014 sHLA-G involved in the apoptosis of decidual natural killer cells following Toxoplasma gondii infection. dNK, ELISA
70  2014 Soluble human leukocyte antigen-G in seminal plasma is associated with HLA-G genotype: possible implications for fertility success. ART, bp
71  2014 The plasma levels of soluble HLA-G molecules correlate directly with CD34+ cell concentration and HLA-G 14bp insertion/insertion polymorphism in cord blood donors. HLA, INS/DEL
72  2014 [Mechanism of HLA-G participation in inhibiting lymphocyte proliferation by amniotic mesenchymal stem cells]. hAMSC, HLA
73  2013 Analyzing HLA-G polymorphisms in children from women with scleroderma. MC, URR, UTR
74  2013 Association of HLA-G promoter and 14-bp insertion-deletion variants with acute allograft rejection and end-stage renal disease. AR, CI, CMV, ESRD, HLA, OR, OS, SNPs
75  2013 HLA-G expression in the peripheral blood of live kidney transplant recipients. HLA-G, iHLA-G, mHLA-G
76  2013 Human leukocyte antigen-G and regulatory T cells during specific immunotherapy for pollen allergy. HLA, Ig, ILT, PBMCs, SIT
77  2013 Incidence and risk factors of anti-HLA immunization after pregnancy. ---
78  2013 Maternal asthma and microRNA regulation of soluble HLA-G in the airway. miR
79  2013 Role of human leukocyte antigen-G 14-base pair polymorphism in kidney transplantation outcomes. 14-bp, HLA-G
80  2013 Soluble HLA-G modulates miRNA-210 and miRNA-451 expression in activated CD4+ T lymphocytes. HBP1, mi, OSR1
81  2013 Soluble human leukocyte antigen G molecule expression in allogeneic hematopoietic stem cell transplantation: good predictor of acute graft-versus-host disease. aGVHD, allo-HSCT, GVHD, HLA-G
82  2013 The expression of human leukocyte antigen G (HLA-G) is associated with sacroiliitis stages of ankylosing spondylitis. AS, FCM, HLA-G, MFI, PBMCs
83  2013 The maternal HLA-G 1597DeltaC null mutation is associated with increased risk of pre-eclampsia and reduced HLA-G expression during pregnancy in African-American women. HLA, PE
84  2012 Analysis of HLA-G polymorphisms in couples with implantation failure. ---
85  2012 Role of HLA-G 14bp deletion/insertion and +3142C>G polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis. CSF, MRI, MS
86  2012 Soluble human leukocyte antigen-g and its insertion/deletion polymorphism in papillary thyroid carcinoma: novel potential biomarkers of disease? HLA-G, HT, PTC
87  2011 Elevated umbilical cord serum TARC/CCL17 levels predict the development of atopic dermatitis in infancy. AD, IP-10, TARC
88  2011 High level of soluble HLA-G in the female genital tract of Beninese commercial sex workers is associated with HIV-1 infection. CSWs
89  2011 HLA-G polymorphisms, genetic susceptibility, and clinical outcome in childhood neuroblastoma. HLA-G
90  2011 Human leukocyte antigen-G expression is associated with a poor prognosis in patients with esophageal squamous cell carcinoma. ELISA, ESCC, HLA, ROC
91  2011 Human leukocyte antigen-G in the male reproductive system and in seminal plasma. HLA
92  2011 Plasma soluble HLA-G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancer. CI, ELISA, HLA-G, ROC
93  2011 Role of 14-bp insertion/deletion polymorphism in HLA-G among Indian women with recurrent spontaneous abortions. HLA, mRNA, RSAs
94  2011 Soluble HLA-G dampens CD94/NKG2A expression and function and differentially modulates chemotaxis and cytokine and chemokine secretion in CD56bright and CD56dim NK cells. NK, PB
95  2011 Soluble human leukocyte antigen G level in fluid from single dominant follicle and the association with oocyte competence. AUC, CI, ELISA, FF, GnRH, HLA-G, IVF
96  2011 Soluble human leukocyte antigen-G (SHLA-G) in Tunisian kidney transplantation. AR
97  2011 Up-regulation of HLA-G expression in cervical premalignant and malignant lesions. AUC, CA125, HLA-G, ROC, SCC
98  2011 [Relationship between the expression of human leukocyte antigen G and preeclampsia]. HLA-G
99  2010 A novel mechanism of soluble HLA-G mediated immune modulation: downregulation of T cell chemokine receptor expression and impairment of chemotaxis. ---
100  2010 Blood soluble human leukocyte antigen G levels are associated with human immunodeficiency virus type 1 infection in Beninese commercial sex workers. 3'UTR, CSWs, HIV-1, HLA